Physician profile
Salman Khalid
NPI 1477832806
$6,359.93
in general payments reported to CMS, 2019-2025
20 companies · $1,528 in 2025
The $1,528 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,775 · 2020: $104 · 2021: $110 · 2022: $1,140 · 2023: $1,289 · 2024: $414 · 2025: $1,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,707 · Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,707.04 |
| Food and Beverage | $1,524.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,996.44 | 2019-2025 | Triclip |
| Boston Scientific Corporation | $1,814.81 | 2022-2023 | Opticross, Avvigo Guidance System |
| Abiomed | $605.39 | 2023-2025 | Impella |
| Medtronic, INC. | $232.57 | 2021-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.32 | 2020-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $57.02 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $56.64 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $55.99 | 2021-2023 | |
| Scpharmaceuticals INC. | $53.96 | 2024 | |
| Inari Medical, INC. | $51.22 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $45.03 | 2020-2022 | |
| Daiichi Sankyo INC. | $39.83 | 2023-2024 | Injectafer, Vanflyta |
| Philips North America LLC | $26.12 | 2020 | |
| Recordati_rare_diseases_inc. | $23.47 | 2024 | Sylvant |
| Impulse Dynamics (USA) INC. | $22.39 | 2023 | Optimizer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $20.71 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.78 | 2021 | |
| Pfizer INC. | $14.81 | 2020 | |
| Irhythm Technologies, INC. | $14.44 | 2024 | Zio Xt Patch, Zio Monitor |
| Baxter Healthcare | $12.99 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.